TRIGLYCERIDE - ANVISA Registration 10300390441

Access comprehensive regulatory information for TRIGLYCERIDE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10300390441 and manufactured by DIALAB GMBH. The registration is held by VYTTRA DIAGNOSTICOS S.A. with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including SIEMENS HEALTHCARE DIAGNOSTICS, INC., BIOSYSTEMS S.A., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10300390441
Registration Details
ANVISA Registration Number: 10300390441
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

TRIGLICÉRIDES DIALAB
Risk Class II

Registration Details

10300390441

25351837010201881

00904728000148

Company Information

DIALAB GMBH
Austria
PT: ÁUSTRIA

Dates and Status

Jan 14, 2019

VIGENTE

09/18/2025 19:00:01